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The prescription of an home ventilator according to different diseases:
from setting to family training
MICHELE VITACCA
Fondazione Salvatore Maugeri IRCCS, Gussago (BS) Italy
In recent years, guidelines have been published
in order to define indications, applications and de-
livering of long-term mechanical ventilation (MV).
Noninvasive positive pressure ventilation (NPPV)
has been increasingly used in the management of
chronic respiratory insufficiency both in restrictive
than in obstructive patients. Side-effects due to the
interface may impact the follow-up of these patients
in 20 to 50 % of cases and account for an impor-
tant problem dealing with discontinuation and lack-
ing of compliance. Nonetheless, selection of pa-
tients, modalities of ventilation, types of ventilators
and their setting, have been claimed to account for
these conflicting results. It is has been described
that only 50% of patients with COPD continued to
use NPPV during prolonged follow-up of appro-
ximately 6 months. In the clinical practice, home
NPPV is prescribed as nasal pressure support ven-
tilation (NPSV), and is set to achieve a decrease in
PaCO2 and an optimal patient’s compliance. We
recently demonstrated that when compared to un-
assisted breathing both settings (at patient’s com-
fort, or the physiological setting) indu-ced a signif-
icant improvement in minute ventilation and in dia-
phragm activity as assessed by the diaphragmatic
pressure-time product (PTP); eva-luation of lung
mechanics and respiratory muscle function may re-
sult in reduction in ineffective ins-piratory efforts.
Home NPPV is often prescribed after in-hospital
practice sessions performed with the commercial
ventilators available at the moment (often a single
one), which may be not necessarily that used by
the patient at home. In our laboratory we under-
took a study to compare the patient-ventilator in-
teraction and patient comfort with different com-
mercial bi-level pressure home ventilators. We con-
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cluded that, in stable awake patients with chronic
ventilatory failure, all these ventilators are well tol-
erated (despite a great intersubject variability in
comfort), and produce similar physiological effects
thus fulfilling the aims of mechanical ventilation. For
that reason the choice of the ventilator for home
NPPV should be done after comparison of differ-
ent ventilators, “tailored” to the individual patient.
The figure try to summarizy the operative flow
chart to set and to monitor an home mechanical
ventilator prescription in a CRF patient from the
first hour of adaptation to the home follow up. In
particulary cardiorespiratory monitoring, portable
polysomnography or complete polysomnography
with a technician represent different steps to per-
form diagnosis of OSAS and to titrate correctely
CPAP prescription.
Only when an accetable ABG response, a noc-
turnal SaTO2 monitoring, a sufficient compliance to
nocturnal ventilation is given, an hospital training for
patient and caregiver is mandatory. The multidisci-
plinary team (doctor, nurse, RT, psicologist) has as
main end points the explanation how the ventilators
works, the side effects, the humidifications prob-
lems, the apparatus cleaning and the trachestomy
care. These lessons (no less than 6 ones of 30 min-
utes each) need clarity and a final test to verify the
family’ level of comprehension. Only at this time
the physician may prescribe the ventilator and dis-
charge the patient. A strict follow up according to
diagnosis to confirm or reconsider indication and
to flow the time course of the program is neces-
sary.
In conclusion a correct home MV program
needs:
1) a well documented diagnosis and indications
2) a well documented test to correct set and appa-
ratus of the ventilator in hospital and after 60 days
since discharge 3) a strict test to verify patient’s
adherence and a program of re-force the prescrip-
tion every year.
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